Literature DB >> 24845739

Clinical features of multiple lung cancers based on thin-section computed tomography: what are the appropriate surgical strategies for second lung cancers?

Aritoshi Hattori1, Kenji Suzuki, Kazuya Takamochi, Shiaki Oh.   

Abstract

PURPOSE: We investigated the proper surgical strategies for second lung cancers based on the findings of thin-section CT.
METHODS: We classified 59 patients with second lung cancers into two categories based on the thin-section CT findings. In the ground glass nodule (GGN) group (n = 29), the first and/or the second lung cancers showed a GGN on thin-section CT. In the Solid group (n = 30), both the first and second lung cancers showed a solid appearance.
RESULTS: The overall 5-year survival rate after second surgery was 71.7 %. The univariate analyses revealed that the presence of more than three lung tumors was significantly more common in the GGN group. Regarding the surgical strategies, all the patients in the GGN group underwent limited resection for at least one of the operations, whereas 36 % of those in the Solid group underwent bilateral lobectomy. The 5-year survival in the GGN group (89.1 %) was significantly better than that in the Solid group (40.8 %) (p = 0.0305).
CONCLUSIONS: Limited resection should be performed for GGN patients as much as possible to preserve lung function, due to the possible presence of more than three lung cancers. Despite the higher likelihood of having more tumors, the GGN patients had a better survival. In contrast, lobectomy for second lesions should be aggressively considered for solid tumor patients whenever possible.

Entities:  

Mesh:

Year:  2014        PMID: 24845739     DOI: 10.1007/s00595-014-0921-5

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  25 in total

1.  Multiple primary cancers or multiple metastases, that is the question.

Authors:  Hisao Asamura
Journal:  J Thorac Oncol       Date:  2010-07       Impact factor: 15.609

2.  Mutations of the P53 tumor suppressor gene as clonal marker for multiple primary lung cancers.

Authors:  T Mitsudomi; Y Yatabe; T Koshikawa; S Hatooka; M Shinoda; M Suyama; T Sugiura; M Ogawa; T Takahashi
Journal:  J Thorac Cardiovasc Surg       Date:  1997-09       Impact factor: 5.209

3.  Stage I lung cancer survivorship: risk of second malignancies and need for individualized care plan.

Authors:  Rakesh Surapaneni; Priya Singh; Kumar Rajagopalan; Alexandre Hageboutros
Journal:  J Thorac Oncol       Date:  2012-08       Impact factor: 15.609

4.  Multiple primary lung cancers.

Authors:  N Martini; M R Melamed
Journal:  J Thorac Cardiovasc Surg       Date:  1975-10       Impact factor: 5.209

5.  Surgical results for multiple primary lung cancers.

Authors:  F Rea; A Zuin; D Callegaro; L Bortolotti; G Guanella; F Sartori
Journal:  Eur J Cardiothorac Surg       Date:  2001-09       Impact factor: 4.191

6.  Radiologic classification of small adenocarcinoma of the lung: radiologic-pathologic correlation and its prognostic impact.

Authors:  Kenji Suzuki; Masahiko Kusumoto; Shun-ichi Watanabe; Ryosuke Tsuchiya; Hisao Asamura
Journal:  Ann Thorac Surg       Date:  2006-02       Impact factor: 4.330

7.  Second primary lung cancer and relapse: treatment and follow-up.

Authors:  C A Angeletti; A Mussi; A Janni; M Lucchi; A Ribechini; A Chella; G Fontanini
Journal:  Eur J Cardiothorac Surg       Date:  1995       Impact factor: 4.191

8.  Survival after resection of synchronous bilateral lung cancer.

Authors:  Paul De Leyn; Johnny Moons; Johan Vansteenkiste; Eric Verbeken; Dirk Van Raemdonck; Philippe Nafteux; Herbert Decaluwe; Tony Lerut
Journal:  Eur J Cardiothorac Surg       Date:  2008-10-01       Impact factor: 4.191

9.  Use of epidermal growth factor receptor/Kirsten rat sarcoma 2 viral oncogene homolog mutation testing to define clonal relationships among multiple lung adenocarcinomas: comparison with clinical guidelines.

Authors:  Nicolas Girard; Charuhas Deshpande; Christopher G Azzoli; Valerie W Rusch; William D Travis; Marc Ladanyi; William Pao
Journal:  Chest       Date:  2009-04-17       Impact factor: 9.410

Review 10.  Surgical treatments for multiple primary adenocarcinoma of the lung.

Authors:  Masao Nakata; Shigeki Sawada; Motohiro Yamashita; Hideyuki Saeki; Akira Kurita; Shigemitsu Takashima; Kazuo Tanemoto
Journal:  Ann Thorac Surg       Date:  2004-10       Impact factor: 4.330

View more
  5 in total

Review 1.  Efficacy of low-dose computed tomography screening for lung cancer: the current state of evidence of mortality reduction.

Authors:  Motoyasu Sagawa; Takafumi Sugawara; Naoya Ishibashi; Akira Koyanagi; Takashi Kondo; Toshiharu Tabata
Journal:  Surg Today       Date:  2016-11-04       Impact factor: 2.549

2.  The oncological outcomes of segmentectomy in clinical-T1b lung adenocarcinoma with a solid-dominant appearance on thin-section computed tomography.

Authors:  Aritoshi Hattori; Takeshi Matsunaga; Kazuya Takamochi; Shiaki Oh; Kenji Suzuki
Journal:  Surg Today       Date:  2015-10-15       Impact factor: 2.549

Review 3.  Controversies on lung cancers manifesting as part-solid nodules.

Authors:  Rowena Yip; Kunwei Li; Li Liu; Dongming Xu; Kathleen Tam; David F Yankelevitz; Emanuela Taioli; Betsy Becker; Claudia I Henschke
Journal:  Eur Radiol       Date:  2017-08-23       Impact factor: 5.315

4.  The impact of chemotherapy on persistent ground-glass nodules in patients with lung adenocarcinoma.

Authors:  Wenwen Lu; Matthew D Cham; Linlin Qi; Jianwei Wang; Wei Tang; Xiaolu Li; Jie Zhang
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

5.  Correlation between histological invasiveness and the computed tomography value in pure ground-glass nodules.

Authors:  Akihiko Kitami; Fumitoshi Sano; Shoko Hayashi; Kosuke Suzuki; Shugo Uematsu; Yoshito Kamio; Takashi Suzuki; Mitsutaka Kadokura; Mutsuko Omatsu; Toshiaki Kunimura
Journal:  Surg Today       Date:  2015-06-30       Impact factor: 2.549

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.